EZH2 and hepatocellular carcinoma: Histone methylation instability has been increasingly implicated in the progression of HCC [79], where aberrant activity of histone methyltransferases (e.g., EZH2) and demethylases alters the expression of genes involved in tumor growth, angiogenesis, and immune evasion.